Language selection

Search

Patent 1337839 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1337839
(21) Application Number: 1337839
(54) English Title: SYNTHESIS OF PEPTIDE AMIDES BY MEANS OF A SOLID PHASE METHOD USING ACID-LABILE ANCHORING GROUPS
(54) French Title: SYNTHESE D'AMIDES PEPTIDIQUES GRACE A UNE METHODE EN PHASE SOLIDE UTILISANT DES GROUPES D'ANCRAGE INSTABLES VIS-A-VIS DES ACIDES
Status: Term Expired - Post Grant
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07K 7/16 (2006.01)
  • C07C 59/70 (2006.01)
  • C07C 271/22 (2006.01)
  • C07K 1/04 (2006.01)
(72) Inventors :
  • BREIPOHL, GERHARD (Germany)
  • KNOLLE, JOCHEN (Germany)
  • STUBER, WERNER (Germany)
(73) Owners :
  • SANOFI-AVENTIS DEUTSCHLAND GMBH
(71) Applicants :
  • SANOFI-AVENTIS DEUTSCHLAND GMBH (Germany)
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued: 1995-12-26
(22) Filed Date: 1988-04-07
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
P 37 11 866.8 (Germany) 1987-04-08

Abstracts

English Abstract


The synthesis of peptide amides by means of a solid phase
method using acid-labile anchoring groups
The invention relates to new compounds of the formula
<IMG> (I)
in which R1 denotes (C1-C9)-alkyl or optionally substi-
tuted (C6-C14)-aryl, R2 denotes hydrogen or an amino acid
residue which is protected by an amino protective group
which can be cleaved off with weak acid or base, R3 de-
notes hydrogen or (C1-C4)-alkyl, and Y1-Y9 denote
identical or different radicals hydrogen, (C1-C4)-alkyl,
(C1-C4)-alkoxy or -O-(CH2)n-COOH (with n = 1 to 6),
one of these radicals being -O-(CH2)n-COOH.
A process for the preparation thereof and the synthesis
of peptide amides by means of a solid phase method using
these new compounds (spacers) are described.


Claims

Note: Claims are shown in the official language in which they were submitted.


- 18 -
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A compound of the formula I
(I)
<IMG>
in which
R1 denotes (C1-C8)-alkyl or (C6-C14)-aryl,
R2 denotes hydrogen or an amino acid residue which is
protected by an amino protective group which can be
cleaved off with weak acid or base,
R3 denotes hydrogen or (C1-C4)-alkyl,
Y1, Y2, Y3, Y4, Y5, Y6, Y7, Y8 and Y9 denote hydrogen,
(C1-C4)-alkyl, (C1-C4)-alkoxy or -O-(CH2)n-COOH,
wherein the radicals may be identical or different
but one radical is -O-(CH2)n-COOH, and
n denotes an integer from 1 to 6.
2. A compound of the formula I as claimed in claim 1, in
which R1 is methyl, and n is an integer 1, 2 or 3.
3. A compound of the formula I as claimed in claim 1, in which
R2 denotes an amino acid residue which is protected with a
urethane protective group, and R3 denotes hydrogen.

- 19 -
4. A compound of the formula I as claimed in claim 1,
2 or 3, in which the radicals Y1, Y2, Y3, Y4, Y5,
Y6, Y7, Y8 and Y9 represent methyl or methoxy,
with, however, one of these radicals denoting, O-
(CH2)n-COOH and at least 4 of these radicals
denoting hydrogen.
5. A compound of the formula I as claimed in claim 1,
2 or 3, in which the radicals Y1, Y3, Y5, Y7, or Y8
represent the radical -O-(CH2)n-COOH.
6. A process for the preparation of a compound of the
formula I as claimed in claim 1, 2 or 3, which
comprises
a) reaction of a compound of the formula II
<IMG> ( II)
in which
R1 denotes (C1-C9)-alkyl or (C6-C14)-aryl,
Y1, Y2, Y3, Y4, Y5, Y6, Y7 , Y8 and Y9 denote hydrogen,
(C1-C4)-alkyl, (C1-C4)-alkoxy or -O-(CH2)n-COOH,
wherein the radicals may be identical or different
but one radical is -O-(CH2)n-COOH, and

- 20 -
n denotes an integer from 1 to 6,
with a compound of the formula III
(III)
<IMG>
in which
R2 denotes hydrogen or an amino acid residue which is
protected by an amino protective group which can be
cleaved off by weak acid or base, and
R3 denotes hydrogen or (C1-C4)-alkyl, or
b) reaction of a compound of the formula IV
<IMG> (IV)
with hydroxylamine to give a compound of the formula V
(V)
<IMG>
in which R1, Y1, Y2, Y3, Y4, Y5, Y6, Y7, Y8,
and Y9 are as defined under a), then reduction of
the oxime to the compound of the formula I, wherein R2 and
R3 denote hydrogen and, wherein the amine may be converted
into derivatives where
R2 denotes hydrogen or an amino acid residue which is
protected by an amino protective group which can be
cleaved off with weak acid or base, and
R3 denotes hydrogen or (C1-C4)-alkyl.

- 21 -
7. A process for the preparation of a peptide of the
formula XI
P-R2-NH-R3 (XI)
in which P represents a peptide residue composed of
q = 1 to 8 .alpha.-amino acids, whereby q p + 1 and p
denotes an integer of 0 to 7, R2 denotes an amino acid
residue, and R3 is as defined in claim 1, by solid
phase synthesis, which comprises coupling a compound
of the formula I as claimed in claim 1, 2 or 3, in
which R2 does not denote hydrogen, to a resin,
cleaving off the protective group on the amino acid
R2, stepwise coupling on of q minus p .alpha.-amino acids
which may be in the form of their activated
derivatives and which have been temporarily protected
by amino protective groups which are base-labile or
labile to weak acids, and, after the synthesis is
complete, liberation of the peptide of the formula XI
from the resin by treatment with a moderately strong
acid, with temporarily introduced side-chain
protective groups being cleaved off again at the same
time or by suitable measures subsequent thereto.
8. A compound of the formula II,
(II)
<IMG>
in which

- 22 -
R1 denotes (C1-C8)-alkyl or (C6-C14)-aryl,
Y1, Y2, Y3, Y4, Y5, Y6, Y7, Y8 and Y9 denote hydrogen,
(C1-C4)-alkyl, (C1-C4)-alkoxy or -O-(CH2)n-COOH, wherein
Y1 - Y9 may be identical or different but one radical
is -O-(CH2)n-COOH, and
n denotes an integer from 1 to 6.
9. The use of a compound of the formula I as claimed in
claim 1, 2 or 3, in which R2 does not denote hydrogen,
in the solid phase synthesis of compounds of the
formula XI
P-R2-NH-R3 (XI)
in which P represents a peptide residue composed of q
p + 1 .alpha.-amino acids, R2 denotes an amino acid residue,
and R3 is as defined in claim l.

Description

Note: Descriptions are shown in the official language in which they were submitted.


1 337839
Specification
The synthesis of peptide amides by means of a solid phase
method using acid-labile anchoring groups
The invention relates to ne~ spacers and processes for the
S preparation thereof, and to the synthesis of peptide amides
by means of a solid phase method using these acid-labile
anchoring groups.
Generally used for the preparation of peptide amides by
means of solid phase synthesis are benzhydrylamine resins
or methylbenzhydrylamine resins as are described in, for
example, J.P. Tam et al., Tetrahedron Lett. 22, 2851
(1981). Another method comprises the ammonolysis of
carrier-bound peptide benzyl esters (C. Ressler et al.,
J. Am. Chem. Soc. 76, 3107 (1951)). Features of both
methods are the strong acid (liquid hydrogen fluoride or
trifluoromethanesulfonic acid) necessary for cleaving off
the spacer, side reactions or incomplete cleavage off.
Hence the invention is based on the object of finding ne~
spacers which allow milder and better cleavage of peptide
amides off from the carrier resin.
This object is achieved according to the invention by the
compounds of the general formula I
R2 R3
N
y~ y9 y1 y2
R1-o ~ CH ~ y3 (I)
y7 y6 y5 y4
in which
R1 denotes (C1-Cg)-alkyl or optionally substituted
(C6-C14)-aryl,
,~

1 337839
2 2 -
R denotes hydrogen or an amino acid residue which is
protected by an amino protective group which can be
cleaved off with weak acid or base,
R3 denotes hydrogen or (C1-C4)-alkyl,
1 2 3 y4 y5 y6 y7 y8 and Y9 denote
hydrogen, (C1-C4)-alkyl, (C1-C4)-alkoxy or
-0-(CH2)n-COOH, it being possible for the radicals
to be identical or different but one radical being
-0-(CH2)n-COOH, and
- 10 n denotes an integer from 1 to 6.
Preferred compounds of the general formula I are those in
which R1 is methyl and n is the integer 1, 2 or 3.
Likewise preferred compounds of this general formula I in
~hich R2 denotes an amino acid residue which is protected
with a urethane protective group, in particular Fmoc, and
R3 denotes hydrogen.
furthermore,.the..radicals y1_y9 represent, in.particular,
methyl or methoxy, with, however, one radical being
-0-(CH2)n-COOH and at least 4 of these radicals being
hydrogen.
25.~ It is preferred for y1~ y3, yS, Y7 or y8 to represent
the radical -0-(CH2)n-COOH.
Alkyl and alkoxy can be straight-chain or branched.
Examples of (C6-C14)-aryl are phenyl, naphthyl, biphenylyl
or fluorenyl; phenyl is preferred.
R2 represents the residue of an amino acid, preferably
of an -amino acid which, if chiral, may be in the D- or
L-form. Preferred residues are those of naturally occur-
ring amino acids, their enantiomers, homologs, derivatives
and simple metabolites (cf., for example, Wunsch et al.,
Houben-~eyl 15/1 and 2, Stuttgart, Thieme 1974). Thus,
the following are suitable examples:

1 337~39
Aad, Abu, yAbu, ABz, 2ABz, ~Aca, Ach, Acp, Adpd, Ahb, Aib,
3Aib, Ala, BAla, ~Ala, Alg, All, Ama, Amt, Ape, Apm, Apr,
Arg, Asn, Asp, Asu, Aze, Azi, Bai, Bph, Can, Cit, Cys,
Cyta, Daad, Dab, Dadd, Dap, Dapm, Dasu, Djen, Dpa, Dtc,
Fel, Gln, Glu, Gly, Guv, hCys, His, hSer, Hyl, Hyp, 3Hyp,
Ile, Ise, Iva, Kyn, Lant, Lcn, Leu, Lsg, Lys, BLys~ ~Lys,
Met, Mim, Min, nArg, Nle, Nva, Oly, Orn, Pan, Pec, Pen,
Phe, Phg, Pic, Pro, ~Pro, Pse, Pya, Pyr, Pza, Qin, Ros,
Sar, Sec, Sem, Ser, Thi, ~Thi, Thr, Thy, Thx, Tia, Tle,
Tly, Trp, Trta, Tyr, Val and the residues of the corres-
ponding enantiomeric D-amino acids.
Functional groups in the side chains of the said amino
acid residues can be protected. Suitable protective
groups are described by Hubbuch, Kontakte (Merck) 1979,
No. 3, pages 14-23, and by Bullesbach, Kontakte (Merck)
1980, No. 1, pages 23-35.
Protective groups which are base-labile or labile to ~eak
acids are, in-particular, urethane protective groups such
as Fmoc, Ddz, Bpoc, Msc, Peoc, Pse and Tse, preferably
Fmoc (see, for example, Hubbuch, Kontakte (Merck) 1979,
No. 3, pages 14-23).
-
The invention also relates to a process for the prepara-
tion of the compounds of the formula I, which comprises
a) reaction of a compound of the formula II
y8 y9 y1 y2
R1-o ~ CH ~ y3 (II)
y7 y6 y5 y4
in which
R1 denotes (C1-Cg)-alkyl or optionally substituted
(c6-c14)-aryl,
1 2 3 y4 y5 y6 y7 y8 and Y9 denote
hydrogen, (C1-C4)-alkyl, (C1-C4)-alkoxy or

1 337839
_
-0-(CH2)n-C00H, it being poss;ble for the radicals to
be identical or different but one radical being
-0-(CH2)n-COOH, and
n denotes an integer from 1 to 6,
~ith a compound of the formula III
H ( I I I )
in which
R2 denotes hydrogen or an amino acid residue which is
protected by an amino protective group ~hich can be
cleaved off by weak acid or base, and
R3 denotes hydrogen or (C1-C4)-alkyl, or
b) reaction of a compound of the formula IV
yB y9 y1 y2
R1_O ~ C ~ Y _ (IV)
y7 y6 y5 y4
with hydroxylamine to give a compound of the formula V
OH
25y8 Y9l y1 y2
R1-O ~ C ~ y3 (V)
y7 y6 y5 y4
in ~hich R1, y1, y2, r3, y4, y5~ y6, y7~ y8 and
Y are as defined above, then reduction of the oxime
to the am;ne, preferab~y with zinc in g~acial acetic
acid (S. Gaehde, G. Matsueda, Int. J. Peptide Protein Res.
18, 451 (1981)) and, where appropriate, conversion into
its derivatives.
The reaction of a compound of the formula Il ~ith a com-
pound of the formula III is preferably carried out in a
polar protic solvent, such as, for example, acetic acid,

1 337839
at a temperature between 0C and the boiling point of the
reaction mixture.
The compounds of the formula II are new.
Compounds of the formula II are obtained, for example, by
reduction of benzophenone derivatives of the formula IV
y8 y9 y1 y2
R1-o ~ C ~ Y3 (IV)
y7 y6 y5 y4
in which R1 y1 y2 y3 y4 y5 y6 y7 y8 and Y9 are as
defined above, with suitable reducing agents, i.e. selec-
tive for the keto group, such as, for example, sodium
borohydride.
Benzophenone derivatives of the formula lV are obtained
a) by reaction of benzophenones of the formula IV,
in which R1 is as defined above, and y1, y2, y3~ y4~ yS
y6, y7~ y8 and Y9 denote hydrogen, (C1-C4)-alkyl or
(C1-C4)-alkoxy, and one of the radicals Y1-Y9 denotes
- hydroxyl, with ~-halogeno fatty acids of the formula VI
Hal-(CH2)n-COOH (VI)
in which Hal denotes halogen, and n is as defined above,
or the esters thereof, there being, in the case of the
esters, subsequent alkaline hydrolysis of the ester group,
for example with sodium hydroxide solution (M. Prashad et
al., Indian J. Chem. 17B, 496-498 (1979)).
b) for example by reaction of benzoyl chlorides of the
formula VII
y8 y9O
R1-o ~ C-Cl (VII)
y7 y6

1 337839
_ - 6
with ~-phenoxyalkanoic acids of the formula VIII
y1 y2
H~O~~CH2)n~COOR4 (VIII)
y5 y4
in which R1 y1 r2 y4 y5 y6 y7 y8 y9 and
n are as defined under a), and R4 denotes (C1-Cg)-alkyl,
preferably methyl or ethyl, with use of a Lewis catalyst
such as, for example, aluminum trichloride or titanium
tetrachloride (Organikum, 13th edition, page 354 (1974)),
or
c) by reaction of the appropriate benzoyl chloride of the
formula VII with appropriately substituted phenols of the
formula IX to give the corresponding phenyl esters of the
formula X
y8 y9 y2 y1
R1--o_~C-O~H
~ - (X)
y7 y6 y4 y5
subsequent Fries isomerization with Lewis acids such as,
for example, titanium tetrachloride (R. Martin et al.,
Monatsh. Chemie 110, 1057-1066 (1979)) and further reac-
tion with ~-halogeno fatty acids of the formula VI, in
which Hal and n are as defined above.
Compounds of the formula VIII are prepared by reaction of
the corresponding phenols of the formula IX
y1 y2
~ (IX)
H ~ OH
ys y4
with the appropriate ~-halogenoalkanoic esters, for exam-
ple ~ith sodium hydride in dimethylformamide (DMF) or
potassium carbonate in acetone.

1 33783~
-- 7
It is also possible to prepare the compounds of the for-
mulae VII, VIII, IX and X corresponding to the general
formula I analogously.
S The invention furthermore relates to the use of a compound
of the formula I in which R2 does not denote hydrogen in
the solid phase synthesis of compounds of the formula XI
P_R2-NH-R3 (XI)
in vhich P represents a peptide residue composed of
q < p+1 ~-amino acids, R2 denotes an amino acid residue
which is protected with an amino protective group which
can be cleaved off with weak acid or base, and R3 is as
defined above, and to a process for the preparation of a
peptide of the formula XI in which P, R2 and R3 are as
defined above, by solid phase synthesis, which comprises
coupling a compound of the formula I, using coupling re-
agents customary in peptide chemistry, via the
-O-(CH2)n-COOH group to ~a resin, cleaving off the protec-
tive group on the amino acid R2, stepwise coupling on of
q-p ~-amino acids which are, where appropriate, in the form
of their activated derivatives and have been temporarily
- protected by amino protective groups which are base-labile
or labile to weak acids, and, after the synthesis is com-
plete, liberation of the peptide of the formula XI from
the resin by treatment with a moderately strong acid, with
temporarily introduced side-chain protective groups being
cleaved off again at the same time or by suitable measures
subsequent thereto.
If necessary to prevent side reactions or for the synthe-
sis of specific peptides, the functional groups in the
side chain of amino acids will be additionally protected
by suitable protective groups (see, for example,
T.W. Greene, "Protective Groups in Organic Synthesis",
New York, John Wiley ~ Sons, 1981), those primarily used
being Arg(Tos), Arg(Mts), Arg(Mtr), Asp(OBzl), Asp(OBut),
Cys(4-MeBzl), Cys(Acm), Cys(SBut), Glu(OBzl), Glu(OBut),

1 337839
His(Tos), His(Fmoc), His(Dnp), His(Trt), Lys(Cl-2),
Lys(Boc), Met(O), Ser(Bzl), Ser(But), Thr(Bzl), Thr(But)
The resins used as carrier material are commercially
available or prepared by us, such as, for example, alkoxy-
benzyl alcohol resins, aminomethyl resins or benzhydryl-
amino resins. Benzhydrylamino resins (BHA) and methyl-O
benzhydrylamino resins (MBHA) are preferred. The loading
is determined by amino acid analysis and/or elemental
analysis.
It is possible to use as coupling reagent for the com-
pound of the formula I and the further amino acid deriva-
tives all possible activating reagents used in peptide
synthesis, see, for example, Houben-Weyl, Methoden der
organischen Chemie (Methods of Organic Chemistry), Band
XV/l, Synthese von Peptiden, Georg Thieme Verlag Stuttgart
1974, but especially carbodiimides such as, for example,
N,N'-dicyclohexylcarbodiimide, N,N'-diisopropylcarbodi-
imide or N-ethyl-N'-(2-dimethylaminopropyl)carbodiimide.
This coupling can be carried out directly by addition of
amino acid derivative with the activating reagent and,
~here appropriate, an additive suppressing racemization,
such as, for example, 4-dimethylaminopyridine, 1-hydroxy-
benzotriazole (HOBt) (~. Konig, R. 6eiger, Chem. Ber.
103, 708 t1970)) or 3-hydroxy-4-oxo-3,4-dihydrobenzotria-
zine (HOObt) (~. Konig, R. Geiger, Chem. Ber. 103, 2054
(1970)) to the resin, or the preactivation of the amino
acid derivative as symmetric anhydride or HOBt or HOObt
ester can be carried out separately, and the solution of
the activated species in a suitable solvent can be added
to the peptide-resin ~hich is ready for coupling.
The coupling and activation of the compound of the for-
mula I and the amino acid derivatives using one of the
abovementioned activating reagents can be carried out in
dimethylformamide or methylene chloride or a mixture of
the two. The activated amino acid derivative is normallv
used in a 1.5- to 4-fold excess. In cases where
,. ~

9 1 337839
incomplete coupling occurs, the coupling reaction is
repeated without previously carrying out the unblocking of
the a-amino group of the peptide-resin which is necessary
for the coupling of the next amino acid in the sequence.
Successful completion of the coupling reaction can be
checked by means of the ninhydrin reaction as described,
for example, by E. Kaiser et al. Anal. Biochem. 34 595
(1970). The synthesis can also be carried out automati-
cally, for example using a model 430A peptide synthesizerfrom Applied Biosystems, it being possible to use either
the synthesis programs provided by the manufacturer of the
apparatus or those constructed by the user himself. The
latter are particularly employed when using amino acid
derivatives protected with the Fmoc group.
The peptide amides are cleaved off from the resin by
treatment with moderately strong acids customarily used in
peptide synthesis (for example trifluoroacetic acid), with
the addition, as cation traps, of substances such as
phenol, cresol, thiocresol, anisole, thioanisole,
ethanedithiol, dimethyl sulfide, ethyl methyl sulfide or
similar cation traps customary in solid phase synthesis,
singly or a mixture of two or more of these auxiliaries.
In this connection, the trifluoroacetic acid can also be
employed diluted with suitable solvents such as, for
example, methylene chloride. The side-chain protective
groups are cleaved off at the same time as the spacer is
cleaved off from the resin.
The crude peptides obtained in this way are purified by
means of chromatography on ~Sephadex, ion exchanger resins
or HPLC.
The examples which follow serve to illustrate the present
invention without intending to restrict it to them.

1 337839
- 10 -
Example 1
Methyl 4-(4-methoxybenzoyl)phenoxyacetate
64 9 of aluminum chloride (anhydrous~ are dissolved in
160 ml of 1,2-dichloroethane, and 71.6 9 of 4-methoxy-
benzoyl chloride are added. 57.6 ml of methyl phenoxy-
acetate are slowly added dropwise, while stirring, and
the reaction mixture is heated at 50C for 4 hours. The
mixture is added dropwise to ice-water, during which an
oil separates out. The aqueous phase is separated off,
and the residue is extracted three times by stirring with
water and is crystallized using methanol. The precipitate
is filtered off and recrystallized from ethyl acetate.
Yield: 54.9 9 (53Z of theory)
Melting point: 146C (148C, ethyl acetate)
Example 2
4-(4-Methoxybenzoyl)phenoxyacetic acid
9.0 9 of the methyl ester (Example -1) are dissolved in
120 ml of 1,2-dimethoxyethane/water (4:1, v:v), and 15
ml of 2N NaOH are added. The mixture is stirred for
three hours, and the pH is adjusted to 3 with 3N HCl.
The organic solvent is evaporated off in vacuo, and the
precipitated product is filtered off, washed with water
and dried under high vacuum.
Yield: 8.4 9 (98Z of theory)
Melting point: 181-182C
Example 3
(4-Carboxymethoxyphenyl)-4-methoxyphenylcarbinol
11.2 9 of 4-(4-methoxybenzoyl)phenoxyacetic acid are dis-
solved in 600 ml of 80% strength methanol (reflux), and
4.4 ml of N-methylmorpholine are added. 6 9 of sodium
borohydride are added in portions over the course of two
hours, and the reaction is continued under reflux con-
ditions for 3 hours. The mixture ;s cooled to room
temperature and acidified to pH 2.5 with 3N HCl. The

1 337839
- 11 -
methanol is distilled off, the aqueous phase is extracted
with ethyl acetate, and the organic phase is washed with
brine and dried over sodium sulfate. After removal of
the ethyl acetate by distillation there remains a white
amorphous powder. The product is used directly for the
next reaction.
Yield: 9.3 9 (83% of theory)
Example 4
Methyl 2-methylyphenoxyacetate
108 9 of 2-methylphenol are dissolved in 500 ml of dry
acetone, and 165.8 9 of powdered potassium carbonate are
added. 113 ml of methyl bromoacetate are added to the
stirred suspension, and the mixture is left to stir at
room temperature with exclusion of moisture. After the
reaction is complete, the salt is filtered off with suc-
tion and washed with acetone, and the filtrate is
concentrated. The residue is taken up in ethyl acetate,
20 - and the organic phase is washed with water, dried over
magnesium sulfate and concentrated.
Yield: 180 9 of an oily liquid which is immedia-
tely reacted further.
Example 5
Methyl 4-(4-methoxybenzoyl)-2-methylphenoxyacetate
146.6 9 of anhydrous aluminum trichloride are dissolved
in 500 ml of 1,2-dichloroethane. At 0C, 187 9 of
4-methoxybenzoyl chloride and 180 9 of methyl 2-methyl-
phenoxy acetate are successively added dropwise. The
mixture ;s heated at 50C to complete the reaction. It
is poured onto ice and the pH is adjusted to 2 with
2N HCl. The precipitated product is filtered off with
suction and washed with water and a little ether. The
precipitate is dissolved in hot ethyl acetate with the
addition of a little active charcoal, and the mixture is
filtered and crystallization is carried out at -10C.
The product is filtered off with suction, washed ~ith

1 337~39
- 12 -
ether and dried under high vacuum.
Yield: 172.8 g (55% of theory)
Melting point: 92-95C
Example 6
Methyl 4-(4-methoxybenzoyl)-2-methylphenoxyacetate
50 9 of 4-hydroxy-3-methyl-4'-methoxybenzophenone
(R. Martin et al. Monatsh. Chemie 110, 1057-1066 (1979))
are dissolved in 200 ml of dry DMF and, under N2, 9 9 of
a 55% dispersion of sod;um hydride in mineral oil are
cautiously added. Then, while stirring, 19.5 ml of methyl
bromoacetate are added dropwise, and the mixture is left
to stand at room temperature overnight. The precipitated
salt is filtered off with suction, and the filtrate is
concentrated in vacuo. The residue is taken up in ethyl
acetate, and the solution is washed with sodium bicarbo-
nate solution and water. The organic phase is dried over
magnesium sulfate, and the solvent is removed in vacuo.
The residue is triturated with ether, filtered off with
suction and dried.
rield: 38.9 9 ~60% of theory)
Melting point: 96-98C
Example 7
Methyl 4-(4-methoxybenzoyl)-phenoxyacetate
29.1 9 of 4-hydroxy-4'-methoxybenzophenone (R. Martin et
al., Monatsh, Chemie 110, 1057-1066 (1979)) are dissolved
in 400 ml of dry acetone. Then, while stirring, 19.3 9
of finely powdered K2C03 and 16 ml of methyl bromo-
acetate are added, and the mixture is stirred at room
temperature. The reaction is complete after 2 days. The
precipitated mixture of salt and substance is filtered
off with suction, and the filtrate is concentrated. Both
residues are suspended in water, and the pH is adjusted
to 3 with 2N HCl. The solid is filtered off with suction,
washed with water and dried under high vacuum in a
desiccator.

_ - 13 - l 3~7~39
Yield: 35.7 9 (98% of theory)
Melting point: 143-145C
Example 8
4-(4-Methoxybenzoyl)-2-methylphenoxyacetic acid
35.8 9 of methyl 4-(4-methoxybenzoyl)-2-methylphenoxy-
acetate are stirred with a mixture of 240 ml of dioxane
and 240 ml of O.SN NaOH at room temperature. After the
reaction is complete, the organic solvent is removed in
vacuo, and the aqueous phase is adjusted to pH 3 with
2N HCl and extracted with ethyl acetate. The organic
phase is ~ashed with ~ater, dried over magnesium sulfate
and concentrated. Pale yello~ crystals remain.
Yield: 30.2 9 (83% of theory)
Melting point: 149-151C
Example 9
(4-Carboxymethoxy-3-methylphenyl)-4-methoxyphenylcarbinol
22.5 9 of 4-(4-methoxybenzoyl)-2-methylphenoxyacetic acid
are dissolved in a mixture of 100 ml of dioxane and 200 ml
of water, adding 1N NaOH to pH 9. 2.8 9 of sodium boro-
hydride are added in portions to the stirred solution,
and the mixture is left to stand overnight. The dioxane
is then removed in vacuo, and the aqueous phase is adjust-
ed to pH 3 with 2N HCl and extracted ~ith ethyl acetate.
The organic phase is dried over magnesium sulfate and
concentrated. A colorless foam remains and is triturated
with n-hexane to give an amorphous powder which is then
filtered off ~ith suction. The product is used directly
for the next reaction.
Yield: 19.2 9 (84% of theory)
Example 10
Methyl 2,6-dimethylphenoxy acetate
65 9 of 2,6-dimethylphenol are dissolved in 200 ml of
dry DMf and, under N2, 23.2 9 of a 55% suspension of
C
,~ . ~. .. ~

1 337839
- 14 -
sodium hydride in mineral oil are added in portions. Then
50.4 ml of methyl bromoacetate are added dropwise with
stirring, and the mixture is left to stand overnight.
The precipitated saLt is filtered off with suction, and
the filtrate is concentrated. The residue is taken up
in ethyl acetate, and the solution is extracted with water.
The organic phase is dried over magnesium sulfate and
concentrated. An oily liquid remains and is used directly
in the following reaction.
Yield: 95.8 9 (92X of theory)
Example 11
Methyl 2,6-dimethyl-4-(4-methoxybenzoyl)phenoxyacetate
The synthesis is carried out in analogy to Example 5 using
19.4 9 of methyl 2,6-dimethylphenoxyacetate.
Yield: 17.4 9 (53X of theory)
Example 12
(4-Carboxymethoxy-3,5-dimethylphenyl)-4-methoxyphenyl-
carbinol
16.4 9 of methyl 2,6-dimethyl-4-(4-methoxybenzoyl)phenoxy-
acetate are stirred in a mixture of 100 ml of 0.5N NaOH
and 100 ml of dioxane at room temperature. After the
hydrolysis of the methyl ester is complete, 1.89 9 of
sodium borohydride are added, and the mixture is left to
react overnight. Then a little insoluble material is
filtered off with suction, the filtrate is concentrated,
and the remaining aqueous solution is acidified with
1N HCl. It is extracted with ethyl acetate, and the
organic phase is washed w;th water, dried over magnesium
sulfate and concentrated. An amorphous powder remains
and is used directly for the subsequent reaction.
Yield: 11.3 9 (71X of theory)
General procedure for the preparation of the (4-carboxy-
methoxyphenyl)-4-methoxyphenylmethylamides of N-Fmoc-
amino acids, and of the (4-carboxymethoxy-3-methylphenyl)-

1 337~39
- - 15 -
4-methoxyphenylmethylamides of N~-Fmoc-amino acids and
of (4-carboxymethoxy-3,5-dimethylphenyl)-4-methoxy-
phenylmethylamides of N-Fmoc-amino acids.
10 mmol of N-Fmoc-amino acid amide and 10 mmol of the
appropriate carbinol are dissolved in the required amount
of glacial acetic acid, and 5-10 drops of concentrated
sulfuric acid are added. 2 9 of molecular sieves are
also added, and the mixture is left to stand overnight.
The molecular sieves are then filtered off with suction,
and the filtrate is diluted with a large amount of ~ater,
~hen part of the product precipitates out. The aqueous
phase is extracted with ethyl acetate, and then the or-
ganic phase is extracted by shaking with ~ater. The
substance remaining after drying over magnesium sulfate
and concentration is recrystallized.
The follo~ing compounds were prepared by the abovemen-
tioned general procedure:
Example 13
(4-Carboxymethoxyphenyl)-4-methoxyphenylmethylamide of
N~-Fmoc-glycine
Yield: 65%
Melting point: 136-138C
Example 14
(4-Carboxymethoxyphenyl)-4-methoxyphenylmethylamide of
N~-Fmoc-phenylalanine
Yield: 65%
Melting point: 159-162C
Example 15
(4-Carboxymethoxy-3-methylphenyl)-4-methoxyphenylmethyl-
amide of N~-Fmoc-glycine
Yield: 60%
Melting point: 135-140C

- 1 337839
~ - 16 -
Example 16
t4-Carboxymethoxy-3-methylphenyL)-4-methoxyphenylmethyl-
amide of N~-Fmoc-valine
Yield: 81X
Melting point: 172-175C
Example 17
(4-Carboxymethoxy-3,5-dimethylphenyl)-4-methoxyphenyl-
methylamide of N~-Fmoc-glycine
Yield: 70%
Melting point: 122-126C
Example 18
Synthesis of oxytocin
H- Cys- Tyr- I le- Gln- Asn- Cys- Pro- Leu- Gly- NH2
using the anchor described in Example 13. The synthesis
was carried out in a peptide synthesizer supplied by
Labotec.
Firstly, the protective group is removed from 1.5 9 of
Boc-Val-resin (loading 0.76 mmol/g) using trifluoroacetic
~ acid in methylene chloride. The resin is washed with
dichloromethane and ethyldiisopropylamine and again with
dichLoromethane and then dried. 2.1 mmol of the anchor
prepared in Example 13 are then added, together with
3.15 mmol of HO~t dissolved in 20 ml of dry DMF, to the
resin, and 2.3 mmol of diisopropylcarbodiimide are added.
The mixture is left to react at room temperature over-
night, stirring slowly. The ninhydrin reaction (Kaiser
test) is used to check that the reaction is complete. The
resin is then filtered off with suction and washed with
DMF, and the peptide is subsequently synthesized on the
resin, carrying out the following steps in cycles:
- Fmoc protective group cleaved off with 20% piperidine
in DMF
- resin washed with DMF
- Fmoc-amino acid coupled on with in situ activation as

1 337839
- - 17 -
HOBt ester and using diisopropylcarbodiimide as acti-
vating reagent (2.1 mmol of amino acid, 3.15 mmol of H08t,
2.3 mmol of diisopropylcarbodiimide)
- resin ~ashed ~ith DMF.
If the coupling is incomplete (Kaiser test), the coupling
step is repeated.
The side-chain protective groups used are tert.-butyl for
1û tyrosine and tert.-butylthio for cystein.
After the synthesis is complete, first the Fmoc protective
group is cleaved off, and then the resin is successively
washed with DMF, dichloromethane, isopropanol, dichloro-
methane and tert.-butyl methyl ether, and is dried under
high vacuum. 2.4 9 of peptide-resin are obtained. Clea-
vage of this is carried out at room temperature using a
mixture of trifluoroacetic acid/thioanisole/ethanedithiol
(8û/15/5). After 2 hours, the mixture is filtered ~ith
-20 suction into tert.-butyl methyl ether, and the precipitated
crude peptide is removed by centrifugation and ~ashed three
times ~ith tert.-butyl methyl ether. The tert.-butylthio
protective group is cleaved off by tributylphosphine in
trifluoroethanol/~ater at pH 7.3. The S-H peptide is
cyclized with iodine in 60% strength acetic acid and is
purified by chromatography on ~Sephadex LH 20 in methanol.
Yield of oxytocin 33%, identical to an authentic compari-
son sample.

Representative Drawing

Sorry, the representative drawing for patent document number 1337839 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: Expired (old Act Patent) latest possible expiry date 2012-12-26
Letter Sent 2006-04-19
Letter Sent 2001-04-27
Grant by Issuance 1995-12-26

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
SANOFI-AVENTIS DEUTSCHLAND GMBH
Past Owners on Record
GERHARD BREIPOHL
JOCHEN KNOLLE
WERNER STUBER
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 1995-12-26 5 112
Abstract 1995-12-26 1 20
Description 1995-12-26 17 539
Cover Page 1995-12-26 1 25
Prosecution correspondence 1995-08-18 1 40
PCT Correspondence 1995-10-18 1 52
Prosecution correspondence 1995-02-14 2 63
Examiner Requisition 1994-10-14 2 103
Prosecution correspondence 1994-06-01 4 164
Examiner Requisition 1994-02-01 2 124
Prosecution correspondence 1991-10-15 2 69
Examiner Requisition 1991-06-13 1 54